Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1261 to 1266 of 1266 entries
Sorted by: Best Match Show Resources per page
Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction.

Biomaterials

Takada T, Sasaki D, Matsuura K, Miura K, Sakamoto S, Goto H, Ohya T, Iida T, Homma J, Shimizu T, Hagiwara N.
PMID: 34979417
Biomaterials. 2021 Dec 30;281:121351. doi: 10.1016/j.biomaterials.2021.121351. Epub 2021 Dec 30.

Alignment, as seen in the native myocardium, is crucial for the fabrication of functional cardiac tissue. However, it remains unclear whether the control of cardiomyocyte alignment influences cardiac function and the underlying mechanisms. We fabricated aligned human cardiac tissue...

Cite
Takada T, Sasaki D, Matsuura K, et al. Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction. Biomaterials. 2021;281:121351doi: 10.1016/j.biomaterials.2021.121351.
Takada, T., Sasaki, D., Matsuura, K., Miura, K., Sakamoto, S., Goto, H., Ohya, T., Iida, T., Homma, J., Shimizu, T., & Hagiwara, N. (2021). Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction. Biomaterials, 281121351. https://doi.org/10.1016/j.biomaterials.2021.121351
Takada, Takuma, et al. "Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction." Biomaterials vol. 281 (2021): 121351. doi: https://doi.org/10.1016/j.biomaterials.2021.121351
Takada T, Sasaki D, Matsuura K, Miura K, Sakamoto S, Goto H, Ohya T, Iida T, Homma J, Shimizu T, Hagiwara N. Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction. Biomaterials. 2021 Dec 30;281:121351. doi: 10.1016/j.biomaterials.2021.121351. Epub 2021 Dec 30. PMID: 34979417.
Copy Download .nbib Format: NLM
Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction.

Biomaterials

Takada T, Sasaki D, Matsuura K, Miura K, Sakamoto S, Goto H, Ohya T, Iida T, Homma J, Shimizu T, Hagiwara N.
PMID: 34979417
Biomaterials. 2021 Dec 30;281:121351. doi: 10.1016/j.biomaterials.2021.121351. Epub 2021 Dec 30.

Alignment, as seen in the native myocardium, is crucial for the fabrication of functional cardiac tissue. However, it remains unclear whether the control of cardiomyocyte alignment influences cardiac function and the underlying mechanisms. We fabricated aligned human cardiac tissue...

Cite
Takada T, Sasaki D, Matsuura K, et al. Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction. Biomaterials. 2021;281:121351doi: 10.1016/j.biomaterials.2021.121351.
Takada, T., Sasaki, D., Matsuura, K., Miura, K., Sakamoto, S., Goto, H., Ohya, T., Iida, T., Homma, J., Shimizu, T., & Hagiwara, N. (2021). Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction. Biomaterials, 281121351. https://doi.org/10.1016/j.biomaterials.2021.121351
Takada, Takuma, et al. "Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction." Biomaterials vol. 281 (2021): 121351. doi: https://doi.org/10.1016/j.biomaterials.2021.121351
Takada T, Sasaki D, Matsuura K, Miura K, Sakamoto S, Goto H, Ohya T, Iida T, Homma J, Shimizu T, Hagiwara N. Aligned human induced pluripotent stem cell-derived cardiac tissue improves contractile properties through promoting unidirectional and synchronous cardiomyocyte contraction. Biomaterials. 2021 Dec 30;281:121351. doi: 10.1016/j.biomaterials.2021.121351. Epub 2021 Dec 30. PMID: 34979417.
Copy Download .nbib Format: NLM
Limitation of Using Ultrasonography After Positive Sentinel Lymph Node Biopsy in a Patient with Melanoma in the Detection of Lymph Node Metastasis.

Yonago acta medica

Goto H, Sugita K, Yamamoto O.
PMID: 34429706
Yonago Acta Med. 2021 Aug 02;64(3):315-317. doi: 10.33160/yam.2021.08.008. eCollection 2021 Aug.

Recent studies have shown that complete lymph node dissection (CLND) performed immediately did not improve the overall survival in patients with sentinel lymph node (LN)-positive melanoma. According to these results, nodal observation with ultrasonography becomes standard. However, it still...

Cite
Goto H, Sugita K, Yamamoto O. Limitation of Using Ultrasonography After Positive Sentinel Lymph Node Biopsy in a Patient with Melanoma in the Detection of Lymph Node Metastasis. Yonago Acta Med. 2021;64(3):315-317doi: 10.33160/yam.2021.08.008.
Goto, H., Sugita, K., & Yamamoto, O. (2021). Limitation of Using Ultrasonography After Positive Sentinel Lymph Node Biopsy in a Patient with Melanoma in the Detection of Lymph Node Metastasis. Yonago acta medica, 64(3), 315-317. https://doi.org/10.33160/yam.2021.08.008
Goto, Hiroyuki, et al. "Limitation of Using Ultrasonography After Positive Sentinel Lymph Node Biopsy in a Patient with Melanoma in the Detection of Lymph Node Metastasis." Yonago acta medica vol. 64,3 (2021): 315-317. doi: https://doi.org/10.33160/yam.2021.08.008
Goto H, Sugita K, Yamamoto O. Limitation of Using Ultrasonography After Positive Sentinel Lymph Node Biopsy in a Patient with Melanoma in the Detection of Lymph Node Metastasis. Yonago Acta Med. 2021 Aug 02;64(3):315-317. doi: 10.33160/yam.2021.08.008. eCollection 2021 Aug. PMID: 34429706; PMCID: PMC8380554.
Copy Download .nbib Format: NLM
Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study.

Drugs - real world outcomes

Tsukada N, Nishikori M, Goto H, Kanamori R, Nishina S, Seto T, Iida S.
PMID: 34455570
Drugs Real World Outcomes. 2021 Aug 29; doi: 10.1007/s40801-021-00276-1. Epub 2021 Aug 29.

BACKGROUND: Plerixafor was approved in Japan in 2016 for peripheral blood stem cell (PBSC) mobilization in autologous stem cell transplantation (A-SCT).OBJECTIVE: Our objective was to evaluate the safety and effectiveness of plerixafor in Japanese patients undergoing A-SCT for various...

Cite
Tsukada N, Nishikori M, Goto H, et al. Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study. Drugs Real World Outcomes. 2021;doi: 10.1007/s40801-021-00276-1.
Tsukada, N., Nishikori, M., Goto, H., Kanamori, R., Nishina, S., Seto, T., & Iida, S. (2021). Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study. Drugs - real world outcomes, . https://doi.org/10.1007/s40801-021-00276-1
Tsukada, Nobuhiro, et al. "Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study." Drugs - real world outcomes vol. (2021). doi: https://doi.org/10.1007/s40801-021-00276-1
Tsukada N, Nishikori M, Goto H, Kanamori R, Nishina S, Seto T, Iida S. Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study. Drugs Real World Outcomes. 2021 Aug 29; doi: 10.1007/s40801-021-00276-1. Epub 2021 Aug 29. PMID: 34455570.
Copy Download .nbib Format: NLM
Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists.

Journal of the Endocrine Society

Yoshida Y, Yoshida R, Shibuta K, Ozeki Y, Okamoto M, Gotoh K, Masaki T, Shibata H.
PMID: 33817540
J Endocr Soc. 2021 Feb 16;5(4):bvab020. doi: 10.1210/jendso/bvab020. eCollection 2021 Apr 01.

CONTEXT: Although primary aldosteronism (PA) reduces quality of life (QOL), there have been no reports on whether treatment with a mineralocorticoid receptor antagonist (MRA) improves QOL in Japanese PA patients.OBJECTIVE: Using the 36-Item Short-Form Health Survey (SF-36), we compared...

Cite
Yoshida Y, Yoshida R, Shibuta K, et al. Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists. J Endocr Soc. 2021;5(4):bvab020doi: 10.1210/jendso/bvab020.
Yoshida, Y., Yoshida, R., Shibuta, K., Ozeki, Y., Okamoto, M., Gotoh, K., Masaki, T., & Shibata, H. (2021). Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists. Journal of the Endocrine Society, 5(4), bvab020. https://doi.org/10.1210/jendso/bvab020
Yoshida, Yuichi, et al. "Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists." Journal of the Endocrine Society vol. 5,4 (2021): bvab020. doi: https://doi.org/10.1210/jendso/bvab020
Yoshida Y, Yoshida R, Shibuta K, Ozeki Y, Okamoto M, Gotoh K, Masaki T, Shibata H. Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists. J Endocr Soc. 2021 Feb 16;5(4):bvab020. doi: 10.1210/jendso/bvab020. eCollection 2021 Apr 01. PMID: 33817540; PMCID: PMC7993577.
Copy Download .nbib Format: NLM
Visualization of dietary docosahexaenoic acid in whole-body zebrafish using matrix-assisted laser desorption/ionization mass spectrometry imaging.

The Journal of nutritional biochemistry

Yoshinaga K, Usami Y, Yoshinaga-Kiriake A, Shikano H, Taira S, Nagasaka R, Tanaka S, Gotoh N.
PMID: 34748923
J Nutr Biochem. 2022 Feb;100:108897. doi: 10.1016/j.jnutbio.2021.108897. Epub 2021 Nov 05.

Zebrafish models have been developed for several studies involving lipid metabolism and lipid-related diseases. In the present study, the migration of dietary docosahexaenoic acid (DHA) in whole-body zebrafish was estimated by stable-isotope tracer and matrix-assisted laser desorption/ionization mass spectrometry...

Cite
Yoshinaga K, Usami Y, Yoshinaga-Kiriake A, et al. Visualization of dietary docosahexaenoic acid in whole-body zebrafish using matrix-assisted laser desorption/ionization mass spectrometry imaging. J Nutr Biochem. 2021;100:108897doi: 10.1016/j.jnutbio.2021.108897.
Yoshinaga, K., Usami, Y., Yoshinaga-Kiriake, A., Shikano, H., Taira, S., Nagasaka, R., Tanaka, S., & Gotoh, N. (2022). Visualization of dietary docosahexaenoic acid in whole-body zebrafish using matrix-assisted laser desorption/ionization mass spectrometry imaging. The Journal of nutritional biochemistry, 100108897. https://doi.org/10.1016/j.jnutbio.2021.108897
Yoshinaga, Kazuaki, et al. "Visualization of dietary docosahexaenoic acid in whole-body zebrafish using matrix-assisted laser desorption/ionization mass spectrometry imaging." The Journal of nutritional biochemistry vol. 100 (2022): 108897. doi: https://doi.org/10.1016/j.jnutbio.2021.108897
Yoshinaga K, Usami Y, Yoshinaga-Kiriake A, Shikano H, Taira S, Nagasaka R, Tanaka S, Gotoh N. Visualization of dietary docosahexaenoic acid in whole-body zebrafish using matrix-assisted laser desorption/ionization mass spectrometry imaging. J Nutr Biochem. 2022 Feb;100:108897. doi: 10.1016/j.jnutbio.2021.108897. Epub 2021 Nov 05. PMID: 34748923.
Copy Download .nbib Format: NLM
Showing 1261 to 1266 of 1266 entries